172 related articles for article (PubMed ID: 36681758)
1. Cholinergic system adaptations are associated with cognitive function in people recently abstinent from smoking: a (-)-[
Calakos KC; Hillmer AT; Anderson JM; LeVasseur B; Baldassarri SR; Angarita GA; Matuskey D; Kapinos M; Zheng MQ; Huang Y; Cosgrove KP
Neuropsychopharmacology; 2023 Mar; 48(4):683-689. PubMed ID: 36681758
[TBL] [Abstract][Full Text] [Related]
2. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
Hillmer AT; Esterlis I; Gallezot JD; Bois F; Zheng MQ; Nabulsi N; Lin SF; Papke RL; Huang Y; Sabri O; Carson RE; Cosgrove KP
Neuroimage; 2016 Nov; 141():71-80. PubMed ID: 27426839
[TBL] [Abstract][Full Text] [Related]
3. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of (-)-[
Bhatt S; Hillmer AT; Nabulsi N; Matuskey D; Lim K; Lin SF; Esterlis I; Carson RE; Huang Y; Cosgrove KP
Synapse; 2018 Mar; 72(3):. PubMed ID: 29105121
[TBL] [Abstract][Full Text] [Related]
5. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.
Gallezot JD; Esterlis I; Bois F; Zheng MQ; Lin SF; Kloczynski T; Krystal JH; Huang Y; Sabri O; Carson RE; Cosgrove KP
Synapse; 2014 Nov; 68(11):556-64. PubMed ID: 25043426
[TBL] [Abstract][Full Text] [Related]
7. (+)-[
Tiepolt S; Becker GA; Wilke S; Cecchin D; Rullmann M; Meyer PM; Barthel H; Hesse S; Patt M; Luthardt J; Wagenknecht G; Sattler B; Deuther-Conrad W; Ludwig FA; Fischer S; Gertz HJ; Smits R; Hoepping A; Steinbach J; Brust P; Sabri O
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):731-746. PubMed ID: 32935187
[TBL] [Abstract][Full Text] [Related]
8. Use of Electronic Cigarettes Leads to Significant Beta2-Nicotinic Acetylcholine Receptor Occupancy: Evidence From a PET Imaging Study.
Baldassarri SR; Hillmer AT; Anderson JM; Jatlow P; Nabulsi N; Labaree D; Cosgrove KP; O'Malley SS; Eissenberg T; Krishnan-Sarin S; Esterlis I
Nicotine Tob Res; 2018 Mar; 20(4):425-433. PubMed ID: 28460123
[TBL] [Abstract][Full Text] [Related]
9. LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.
Ludwig FA; Smits R; Fischer S; Donat CK; Hoepping A; Brust P; Steinbach J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617996
[TBL] [Abstract][Full Text] [Related]
10. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
[TBL] [Abstract][Full Text] [Related]
11. Recently Abstinent Smokers Exhibit Mood-Associated Dopamine Dysfunction in the Ventral Striatum Compared to Nonsmokers: A [11C]-(+)-PHNO PET Study.
Calakos KC; Hillmer AT; Angarita GA; Baldassarri SR; Najafzadeh S; Emery PR; Matuskey D; Huang Y; Cosgrove KP
Nicotine Tob Res; 2022 Mar; 24(5):745-752. PubMed ID: 34628508
[TBL] [Abstract][Full Text] [Related]
12. PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding.
Hillmer AT; Wooten DW; Farhoud M; Higgins AT; Lao PJ; Barnhart TE; Mukherjee J; Christian BT
Synapse; 2013 Dec; 67(12):882-6. PubMed ID: 23913347
[TBL] [Abstract][Full Text] [Related]
13. PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders.
Tiepolt S; Meyer PM; Patt M; Deuther-Conrad W; Hesse S; Barthel H; Sabri O
J Nucl Med; 2022 Jun; 63(Suppl 1):33S-44S. PubMed ID: 35649648
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of α4β2-nicotinic acetylcholine receptors.
Smits R; Fischer S; Hiller A; Deuther-Conrad W; Wenzel B; Patt M; Cumming P; Steinbach J; Sabri O; Brust P; Hoepping A
Bioorg Med Chem; 2014 Jan; 22(2):804-12. PubMed ID: 24369841
[TBL] [Abstract][Full Text] [Related]
15. Influence of acetylcholine levels on the binding of a SPECT nicotinic acetylcholine receptor ligand [123I]5-I-A-85380.
Fujita M; Al-Tikriti MS; Tamagnan G; Zoghbi SS; Bozkurt A; Baldwin RM; Innis RB
Synapse; 2003 Jun; 48(3):116-22. PubMed ID: 12645036
[TBL] [Abstract][Full Text] [Related]
16. Lower Dopamine D2/3 Receptor Availability is Associated With Worse Verbal Learning and Memory in People Who Smoke Cigarettes.
Zakiniaeiz Y; Gueorguieva R; Peltier MR; Roberts W; Verplaetse TL; Burke C; Morris ED; McKee SA; Cosgrove KP
Nicotine Tob Res; 2023 Apr; 25(5):1047-1051. PubMed ID: 36107715
[TBL] [Abstract][Full Text] [Related]
17.
Coughlin JM; Slania S; Du Y; Rosenthal HB; Lesniak WG; Minn I; Smith GS; Dannals RF; Kuwabara H; Wong DF; Wang Y; Horti AG; Pomper MG
J Nucl Med; 2018 Oct; 59(10):1603-1608. PubMed ID: 29496987
[TBL] [Abstract][Full Text] [Related]
18. In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.
Esterlis I; Ranganathan M; Bois F; Pittman B; Picciotto MR; Shearer L; Anticevic A; Carlson J; Niciu MJ; Cosgrove KP; D'Souza DC
Biol Psychiatry; 2014 Sep; 76(6):495-502. PubMed ID: 24360979
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
[TBL] [Abstract][Full Text] [Related]
20. The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380.
Ellis JR; Nathan PJ; Villemagne VL; Mulligan RS; Ellis KA; Tochon-Danguy HJ; Chan JG; O'keefe GJ; Bradley J; Savage G; Rowe CC
Synapse; 2009 Sep; 63(9):752-63. PubMed ID: 19484724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
